Bruker advances functional proteomics with novel timsUltra AIP and timsOmni workflows

BRKR•2026-09-28

Bruker introduced timsUltra AIP and timsOmni workflows for drug discovery and development and disease biology research.

1. New proteomics workflows

Bruker said it is advancing functional proteomics with novel timsUltra AIP and timsOmni workflows for drug discovery and development and disease biology research.

Bruker advances functional proteomics with novel timsUltra AIP and timsOmni workflows

1. New proteomics workflows

Related News

Dutch Bros Inc.: D.A. Davidson cuts target price to $60 from $85

Torex Gold Resources raises target price to C$89 from C$71

Merck licenses SciBrunch cancer drug in deal worth up to $2.13 billion

FIS integrates Spade real-time transaction enrichment into debit processing platform

NETSOL Technologies Inc. Q4 revenue $20.7 million